Cargando…

A Specific Mini‐Intrabody Mediates Lysosome Degradation of Mutant Huntingtin

Accumulation of misfolded proteins leads to many neurodegenerative diseases that can be treated by lowering or removing mutant proteins. Huntington's disease (HD) is characterized by the intracellular accumulation of mutant huntingtin (mHTT) that can be soluble and aggregated in the central ner...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Caijuan, Lin, Yingqi, Chen, Yizhi, Song, Xichen, Zheng, Xiao, Li, Jiawei, He, Jun, Chen, Xiusheng, Huang, Chunhui, Wang, Wei, Wu, Jianhao, Wu, Jiaxi, Gao, Jiale, Tu, Zhuchi, Li, Xiao‐Jiang, Yan, Sen, Li, Shihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625127/ https://www.ncbi.nlm.nih.gov/pubmed/37688357 http://dx.doi.org/10.1002/advs.202301120

Ejemplares similares

A Specific Mini‐Intrabody Mediates Lysosome Degradation of Mutant Huntingtin (Adv. Sci. 31/2023)
por: Li, Caijuan, et al.
Publicado: (2023)

Intravenous AAV9 administration results in safe and widespread distribution of transgene in the brain of mini-pig
por: Lin, Yingqi, et al.
Publicado: (2023)

Generation of inactivated IL2RG and RAG1 monkeys with severe combined immunodeficiency using base editing
por: Zheng, Xiao, et al.
Publicado: (2023)

Bifunctional Anti-Huntingtin Proteasome-Directed Intrabodies Mediate Efficient Degradation of Mutant Huntingtin Exon 1 Protein Fragments
por: Butler, David C., et al.
Publicado: (2011)

Application of CRISPR/Cas9 System in Establishing Large Animal Models
por: Lin, Yingqi, et al.
Publicado: (2022)

Perturbation with Intrabodies Reveals That Calpain Cleavage Is Required for Degradation of Huntingtin Exon 1
por: Southwell, Amber L., et al.
Publicado: (2011)

Huntingtin exon 1 deletion does not alter the subcellular distribution of huntingtin and gene transcription in mice
por: Zhao, Xianxian, et al.
Publicado: (2022)

Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form
por: Yang, Huiming, et al.
Publicado: (2020)

Huntingtin Interacting Proteins and Pathological Implications
por: Liu, Li, et al.
Publicado: (2023)

Author Correction: Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form
por: Yang, Huiming, et al.
Publicado: (2020)

N-terminal Huntingtin Knock-In Mice: Implications of Removing the N-terminal Region of Huntingtin for Therapy
por: Liu, Xudong, et al.
Publicado: (2016)

Tauopathy promotes spinal cord-dependent production of toxic amyloid-beta in transgenic monkeys
por: Tu, Zhuchi, et al.
Publicado: (2023)

Rhes depletion promotes striatal accumulation and aggregation of mutant huntingtin in a presymptomatic HD mouse model
por: Pan, Yongcheng, et al.
Publicado: (2023)

Intrabody Expression in Mammalian Cells
por: Biocca, Silvia
Publicado: (2011)

Lack of interleukin-1 type 1 receptor enhances the accumulation of mutant huntingtin in the striatum and exacerbates the neurological phenotypes of Huntington's disease mice
por: Wang, Chuan-En, et al.
Publicado: (2010)

IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome
por: Thompson, Leslie Michels, et al.
Publicado: (2009)

Synaptic mutant huntingtin inhibits synapsin-1 phosphorylation and causes neurological symptoms
por: Xu, Qiaoqiao, et al.
Publicado: (2013)

Reduction of mutant huntingtin accumulation and toxicity by lysosomal cathepsins D and B in neurons
por: Liang, Qiuli, et al.
Publicado: (2011)

Huntingtin coordinates the dynein-mediated dynamic positioning of endosomes and lysosomes
por: Caviston, Juliane P., et al.
Publicado: (2011)

Genetically modified large animal models for investigating neurodegenerative diseases
por: Yang, Weili, et al.
Publicado: (2021)

Modeling and Characterization of Capacitive Coupling Intrabody Communication in an In-Vehicle Scenario
por: Xu, Yuan, et al.
Publicado: (2019)

CRISPR/Cas9-mediated PINK1 deletion leads to neurodegeneration in rhesus monkeys
por: Yang, Weili, et al.
Publicado: (2019)

Huntingtin-Associated Protein 1 in Mouse Hypothalamus Stabilizes Glucocorticoid Receptor in Stress Response
por: Chen, Xingxing, et al.
Publicado: (2020)

Conditional Inactivation of HIF-1 Using Intrabodies
por: Groot, Arjan J., et al.
Publicado: (2008)

Specific in vivo knockdown of protein function by intrabodies
por: Marschall, Andrea LJ, et al.
Publicado: (2015)

Targeting tauopathy with engineered tau-degrading intrabodies
por: Gallardo, Gilbert, et al.
Publicado: (2019)

Blocking phospholamban with VHH intrabodies enhances contractility and relaxation in heart failure
por: De Genst, Erwin, et al.
Publicado: (2022)

Mitochondrial-Dependent and Independent Functions of PINK1
por: Chen, Xiusheng, et al.
Publicado: (2022)

Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity
por: Shin, Ji-Yeon, et al.
Publicado: (2005)

A novel intrabody communication transceiver for biomedical applications
por: Seyedi, Mir Hojjat, et al.
Publicado: (2017)

Assembly and Folding Properties of Cytosolic IgG Intrabodies
por: Seo, Youngsil, et al.
Publicado: (2020)

Intrabody-based FRET probe to visualize endogenous histone acetylation
por: Chung, Chan-I, et al.
Publicado: (2019)

The intrabody targeting of hTERT attenuates the immortality of cancer cells
por: Zhu, Xiangying, et al.
Publicado: (2009)

Fuzzy Logic and Bio-Inspired Firefly Algorithm Based Routing Scheme in Intrabody Nanonetworks
por: Fahim, Hamza, et al.
Publicado: (2019)

A synthetic intrabody based selective and generic inhibitor of GPCR endocytosis
por: Ghosh, Eshan, et al.
Publicado: (2017)

Molecular cloning and characterization of a novel anti-TLR9 intrabody
por: Reimer, Elisa, et al.
Publicado: (2013)

Light-guided intrabodies for on-demand in situ target recognition in human cells
por: Joest, Eike F., et al.
Publicado: (2021)

Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions
por: Böldicke, Thomas
Publicado: (2022)

An Intrabody Drug (rAAV6-INT41) Reduces the Binding of N-Terminal Huntingtin Fragment(s) to DNA to Basal Levels in PC12 Cells and Delays Cognitive Loss in the R6/2 Animal Model
por: Amaro, I. Alexandra, et al.
Publicado: (2016)

Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin
por: Wang, Chuan-En, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_3imiudsq32a0krv1lgf6qo6kvp